Safety and Efficacy of Low-dose Prasugrel in the Endovascular Treatment of Unruptured Aneurysms in the Elders (≥ 75 Years)

[1]  M. Hayakawa,et al.  Reduction of thromboembolic complications during the endovascular treatment of unruptured aneurysms by employing a tailored dual antiplatelet regimen using aspirin and prasugrel , 2021, Journal of NeuroInterventional Surgery.

[2]  D. Suh,et al.  Tailored antiplatelet agent medication in clopidogrel hyporesponsive patients before stent-assisted coiling: single-center experience , 2020, Neuroradiology.

[3]  A. Ogawa,et al.  Safety and Efficacy of Prasugrel in Elderly/Low Body Weight Japanese Patients with Ischemic Stroke: Randomized PRASTRO-II , 2020, Cerebrovascular Diseases.

[4]  H. Naito,et al.  The Usefulness of Prasugrel as Rescue Medication in Neuroendovascular Therapy , 2020, Journal of neuroendovascular therapy.

[5]  Marco Valgimigli,et al.  2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. , 2019, European heart journal.

[6]  I. Oran,et al.  Aggregometry Response to Half-dose Prasugrel in Flow-diverting Stent Implantation , 2019, Clinical Neuroradiology.

[7]  O. Kwon,et al.  Trends in the Incidence and Treatment of Cerebrovascular Diseases in Korea : Part I. Intracranial Aneurysm, Intracerebral Hemorrhage, and Arteriovenous Malformation , 2019, Journal of Korean Neurosurgical Society.

[8]  A. Bonafe,et al.  Comparison of Prasugrel and Clopidogrel Used as Antiplatelet Medication for Endovascular Treatment of Unruptured Intracranial Aneurysms: A Meta-Analysis , 2019, American Journal of Neuroradiology.

[9]  M. Han,et al.  Low-Dose Prasugrel vs Clopidogrel-Based Tailored Premedication for Endovascular Treatment of Cerebral Aneurysms. , 2018, Neurosurgery.

[10]  M. Han,et al.  Antiplatelet Premedication for Stent-Assisted Coil Embolization of Intracranial Aneurysms: Low-Dose Prasugrel vs Clopidogrel , 2018, Neurosurgery.

[11]  Minkyu Han,et al.  Low-Dose Prasugrel in Patients with Resistance to Clopidogrel for the Treatment of Cerebral Aneurysms , 2018, Neurointervention.

[12]  O. Kwon,et al.  Prophylactic Antiplatelet Medication in Endovascular Treatment of Intracranial Aneurysms: Low-Dose Prasugrel versus Clopidogrel , 2016, American Journal of Neuroradiology.

[13]  B. Pukenas,et al.  Heterogeneous practice patterns regarding antiplatelet medications for neuroendovascular stenting in the USA: a multicenter survey , 2014, Journal of NeuroInterventional Surgery.

[14]  G. M. Jones,et al.  Prevention of stent thrombosis with reduced dose of prasugrel in two patients undergoing treatment of cerebral aneurysms with pipeline embolisation devices , 2012, Journal of NeuroInterventional Surgery.

[15]  M. Reynolds,et al.  Hemorrhagic complications after prasugrel (Effient) therapy for vascular neurointerventional procedures , 2012, Journal of NeuroInterventional Surgery.

[16]  R. Nogueira,et al.  Novel use of prasugrel for intracranial stent thrombosis , 2011, Journal of NeuroInterventional Surgery.

[17]  B. Kwon,et al.  Preinterventional Clopidogrel Response Variability for Coil Embolization of Intracranial Aneurysms: Clinical Implications , 2010, American Journal of Neuroradiology.

[18]  G. Duckwiler,et al.  Endovascular Coiling of Intracranial Aneurysms in Elderly Patients: Report of 205 Treated Aneurysms , 2010, Neurosurgery.

[19]  K. Winters,et al.  Effect of Age on the Pharmacokinetics and Pharmacodynamics of Prasugrel during Multiple Dosing , 2009, Drugs & aging.

[20]  S. Wiviott.  Intensity of antiplatelet therapy in patients with acute coronary syndromes and percutaneous coronary intervention: the promise of prasugrel? , 2008, Cardiology clinics.

[21]  E. Antman,et al.  Prasugrel versus clopidogrel in patients with acute coronary syndromes. , 2007, The New England journal of medicine.

[22]  A. Jaffe,et al.  Thrombolysis in myocardial infarction (TIMI) trial—Phase I: Hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase , 1988 .